Table 3.
Incidental finding n = 320 |
Symptomatic patients n = 273 |
P | |||
---|---|---|---|---|---|
Age (mean, SD) | 61.93 | 9.8 | 59.51 | 10.1 | 0.007 |
Male (n, %) | 212 | 66% | 200 | 73% | 0.054 |
Never smoker | 50 | 15.6% | 18 | 6.6% | 0.003 |
Previous malignancy | 41 | 13% | 13 | 5% | 0.002 |
Pathological staging (n, %) | |||||
IA | 121 | 37.81 | 36 | 13.19 | 0.0001 |
IB | 71 | 22.19 | 52 | 19.05 | |
IIA | 16 | 5.00 | 10 | 3.66 | |
IIB | 40 | 12.50 | 50 | 18.32 | |
IIIA | 46 | 14.38 | 86 | 31.50 | |
IIIB | 15 | 4.69 | 24 | 8.79 | |
IV | 11 | 3.44 | 15 | 5.49 | |
Squamous cell | 51 | 16% | 63 | 23.1% | 0.031 |
Adenocarcinoma | 214 | 66.9% | 147 | 53.8% | 0.025 |
Pneumonectomy | 10 | 3.1% | 28 | 11% | 0.005 |
Tumor size >3 cm | 149 | 46.5 | 200 | 73% | 0.0001 |
Central tumor location | 60 | 18.75 | 99 | 36.20% | 0.001 |
Resection considered curative | 288 | 90% | 220 | 81% | 0.007 |
Postoperative complication rate | 57 | 17.8% | 73 | 26.7% | 0.022 |
ICU stay days (mean, SD) | 1.73 | 3.209 | 1.44 | 4.388 | 0.38 |
Operative mortality | 11 | 3.6% | 17 | 6.2% | 0.355 |